Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) - Retinitis Pigmentosa GTPase Regulator (RPGR)

Clinical trial NCT03252847 · COMPLETED

Trial details

NCT number: NCT03252847
Sponsor: MeiraGTx UK II Ltd
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

X-Linked Retinitis Pigmentosa

Start date: 2017-07-31
Primary completion: 2021-11-18
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.